Proactive TDM for Crohn's Disease Patients in Clinical Remission Under Anti-TNF Treatment: Current State of Evidence

J Crohns Colitis. 2020 Sep 16;14(9):1338-1339. doi: 10.1093/ecco-jcc/jjaa043.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adalimumab
  • Crohn Disease*
  • Humans
  • Infliximab
  • Tumor Necrosis Factor Inhibitors*

Substances

  • Tumor Necrosis Factor Inhibitors
  • Infliximab
  • Adalimumab